
The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant
By Fran Hawthorne
Publisher: Wiley
Number Of Pages: 304
Publication Date: 2003-02-28
ISBN-10 / ASIN: 0471228788
ISBN-13 / EAN: 9780471228783
Product Description:
An in-depth look at big pharma’s flagship company
The Merck Druggernaut takes readers inside Merck, the world’s second most profitable drug company and maker of the world’s bestselling drug, Prilosec. Consistently named one of Fortune magazine’s Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It’s a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business’s most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business.
Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain’s New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain’s, she spearheads the publication of two to three special healthcare issues per year.
Summary: good book on how pharmaceutical companies operate.
Rating: 3
the book is an eye opener for those who have no idea of how a pharmaceutical company operates. it is very detailed from the conception of a drug to its marketing. it praises and also hits the pharmaceutical industry.
well written and easy to understand. highly recommended.
Summary: A good reminder that not all pharma is evil
Rating: 5
Merck is one of the most honest drug companies in the world. Given their recent troubles with Vioxx it is good to have a book out there that reminds us of the good things they have done. Hawthorne as always is well written and does a great job of taking us from the founding with George Merck to the present day and the quest to create new drugs. It is an unbiased perspective that may make those who want to blame big Pharma for all of their ills. Highly recommend.
Summary: Pretty interesting book
Rating: 4
This book covers not only Merck, but also big pharma in general. I enjoyed reading the book, too bad that all the events post-Vioxx recall are mentioned only in the Epilogue.
Summary: Delivers the goods.
Rating: 4
This book was everything I hoped. Very well written, researched, and organized. I don’t know what more a reader could have wanted than what Hawthorne hath writ.
Unlike what other critics here seem to have assumed, the book is *not* an expose. In fact, Hawthorne indicates repeatedly that Merck’s employees and alumni are famously a tight-lipped bunch. In light of that, I think she did an outstanding job of lifting the veneer to peek into the company’s ethos, zeitgeist, and birthright.
The book does an admirable job of staying centered on Merck as the subject, rather than shifting to the drug industry as the star of the show and Merck but a player in it. Perhaps a couple of the middle chapters spent more time reversing these roles than I’d have liked, but sometimes that’s necessary when an industry sea change makes the company the object rather than the subject.
In all an excellent read, especially for someone (like me) who is considering a career in the industry.
Randy
Summary: Regurgitation of Merck’s PR handouts
Rating: 1
As an ex-Merck employee who was there during the stellar days of Roy Vagelos and has had to watch Ray Gilmartin and Peter Kim squander the legacy and the public trust of a once distinguished phramaceutical company, I take great exception to this trite, inaccurate “informmercial” of a book. The give away is the opening page - the Merck superman, not above fixing his own plumbing problems. Clark Kent where are you?
This book is pathetic - stealing directly from Merck’s circa 2000 PR materials. No mention of the great pharmacologists and medicinal chemistrs who set the stage for P. Roy’s success - Clem Stone, Karl Beyer, Ralph Hirschmann, Paul Anderson, Brad Clineschimdt - just the story post Roy - with a number of patheric legends in their own minds taking center stage and leading Merck straight into the COX-2 fiasco.
Merck once had great leadership, now it has Gilmartin’s Don Knotts to George Merck’s Andy Griffith.
This book is worthless
Please Login or Register to read the rest of this content.
Random Posts
- Monkeys of the Ta iuml; Forest: An African Primate Community (Cambridge Studies in Biological and Evolutionary Anthropology) (0)
- Kaplan Video - USMLE Step 2 CK - Neurology (0)
- Primer of Genetic Analysis: A Problems Approach (0)
- Developmental Psychobiology: An Interdisciplinary Science (0)
- Human Protein Data - 2 Volume Set (0)
- Pulmonary Arterial Hypertension: A Pocketbook guide (0)